Elisha M. Wachman, MD

Associate Professor, Pediatrics

Elisha Wachman
617.414.3690

Biography

Dr. Wachman received her MD from the BU School of Medicine before pursuing her pediatric residency at Boston Medical Center (BMC) and Children’s Hospital Boston. She then completed her neonatology fellowship at the Floating Hospital for Children at Tufts Medical Center. She is currently an attending neonatologist at BMC and a leader in neonatal abstinence syndrome (NAS) quality improvement and research at BMC. Her research interests include the genetics and epigenetics of NAS, breastfeeding in the setting of maternal substance use disorders, and the use of non-pharmacologic care methods to improve NAS outcomes. She is the neonatal lead of the Massachusetts (MA) neoQIC NAS Quality Improvement Collaborative. She was a site investigator in a NIDA funded clinical trial comparing the short-term and long-term outcomes of methadone versus morphine for NAS and is currently the principal investigator of a NICHD funded study examining the safety, efficacy, pharmacokinetics, pharmacogenomics, and long-term maternal and infant outcomes of extended-release naltrexone for pregnant women with opioid use disorder.

Education

  • Boston University School of Medicine, MD
  • Georgetown University, BS

Classes Taught

  • GMSMS710

Publications

  • Published on 8/25/2020

    Taglauer E, Benarroch Y, Rop K, Barnett E, Sabharwal V, Yarrington C, Wachman EM. Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads. Placenta. 2020 10; 100:69-74. PMID: 32862058.

    Read at: PubMed
  • Published on 8/13/2020

    Sen S, Andrews C, Anderson E, Turner D, Monthé-Drèze C, Wachman EM. Type of feeding provided with dextrose gel impacts hypoglycemia outcomes: comparing donor milk, formula, and breastfeeding. J Perinatol. 2020 Aug 13. PMID: 32792637.

    Read at: PubMed
  • Published on 7/16/2020

    Wachman EM, Houghton M, Melvin P, Isley BC, Murzycki J, Singh R, Minear S, MacMillan KDL, Banville D, Walker A, Mitchell T, Galimi-Hayes R, Jorgensen S, Gomes DR, Hodgins F, Whalen BL, Diop H, Gupta M. A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care tool in Massachusetts' PNQIN collaborative. J Perinatol. 2020 Oct; 40(10):1560-1569. PMID: 32678314.

    Read at: PubMed
  • Published on 7/1/2020

    Jones HE, Kaltenbach K, Benjamin T, Wachman EM, O'Grady KE. Letter-in-reply. J Addict Med. 2020 Jul/Aug; 14(4):354-355. PMID: 31972769.

    Read at: PubMed
  • Published on 4/27/2020

    Winhusen T, Lofwall M, Jones HE, Wilder C, Lindblad R, Schiff DM, Wexelblatt S, Merhar S, Murphy SM, Greenfield SF, Terplan M, Wachman EM, Kropp F, Theobald J, Lewis M, Matthews AG, Guille C, Silverstein M, Rosa C. Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations. Contemp Clin Trials. 2020 06; 93:106014. PMID: 32353544.

    Read at: PubMed
  • Published on 3/1/2020

    Wachman EM. How Might Maternal Poverty Impact the Course of Neonatal Opioid Withdrawal Syndrome? J Addict Med. 2020 Mar/Apr; 14(2):93-94. PMID: 31149916.

    Read at: PubMed
  • Published on 1/24/2020

    Czynski AJ, Davis JM, Dansereau LM, Engelhardt B, Marro P, Bogen DL, Hudak ML, Shenberger J, Wachman EM, Oliveira EL, Lester BM. Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome. J Pediatr. 2020 04; 219:146-151.e1. PMID: 31987653.

    Read at: PubMed
  • Published on 9/5/2019

    Stulac S, Bair-Merritt M, Wachman EM, Augustyn M, Howard C, Madoor N, Costello E. Children and families of the opioid epidemic: Under the radar. Curr Probl Pediatr Adolesc Health Care. 2019 08; 49(8):100637. PMID: 31494050.

    Read at: PubMed
  • Published on 8/19/2019

    Minear S, Wachman EM. Management of Newborns with Prenatal Opioid Exposure: One Institution's Journey. Clin Ther. 2019 09; 41(9):1663-1668. PMID: 31439335.

    Read at: PubMed
  • Published on 7/27/2019

    Wachman EM, Saia K, Miller M, Valle E, Shrestha H, Carter G, Werler M, Jones H. Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects. Clin Ther. 2019 09; 41(9):1681-1689. PMID: 31358302.

    Read at: PubMed

View 31 more publications: View full profile at BUMC

View all profiles